Molecular Partners AG (XSWX:MOLN)
CHF 3.305 -0.115 (-3.36%) Market Cap: 108.63 Mil Enterprise Value: -74.61 Mil PE Ratio: 0 PB Ratio: 0.64 GF Score: 53/100

Molecular Partners AG at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 05:15PM GMT
Release Date Price: CHF16.3 (-0.12%)
David Neil Lebowitz
Morgan Stanley, Research Division - VP

Hello, and welcome again to the Morgan Stanley 18th Annual Global Health Care Conference. I'm one of the analysts here -- biotech analyst. My name is David Lebowitz. Before we get going, let me just go through the requisite disclosures.

Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

I have with me, in our next session, from Molecular Partners, CEO, Patrick Amstutz; and the Head of Investor Relations, Seth Lewis.

Questions & Answers

David Neil Lebowitz
Morgan Stanley, Research Division - VP

I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot